#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neonatal asphyxia Interstitial lung disease Small intestine adenocarcinoma Warm autoimmune haemolytic anaemia Angelman's syndrome Iron overload Retinal dystrophy Non-small cell lung cancer recurrent IPEX syndrome Neuroendocrine carcinoma Advanced systemic mastocytosis Anaplastic thyroid cancer Synovial sarcoma Encephalitis autoimmune Extra-osseous Ewing's sarcoma metastatic More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Treatment Thrombotic thrombocytopenic purpura Urea cycle disorder – Treatment Waldenstrom’s macroglobulinaemia refractory – Treatment Antisynthetase syndrome Glycogen storage disease type II – Trials in Disease Acute respiratory distress syndrome – Basic Information Angiosarcoma recurrent Haemophilia A with anti factor VIII – Life with Disease Undifferentiated sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Etoposide Phosphate Vudalimab Sodium Sulfate Anhydrous Xxb750 Lorlatinib WEF-001 Brinzolamide Blu-263 Phosphate Imipramine Hydrochloride Nms-03592088 Sotorasib Felis Domesticus (555) Digoxin Immune Fab (Ovine) Imatinib Taurine SIGVOTATUG VEDOTIN Tigecycline Sym024 Tirzepatide FERUMOXTRAN-10 More therapies…

    Learn about Your Condition

    T-cell lymphoma Pyoderma Ectopic pregnancy Autism spectrum disorder Peritoneal neoplasm Reperfusion injury Lip and/or oral cavity cancer Inguinal hernia Primary hyperoxaluria Device related infection Glycogen storage disorder Dry mouth Milk allergy Skin cancer Noninfective chorioretinitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Med Polonia Sp. z o.o.

Med Polonia Sp. z o.o.

Obornicka 262, Poznan, 60-693, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of DT-DEC01 for Patients with Duchenne Muscular Dystrophy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Poland

  • Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Pembrolizumab
    Austria Belgium France Germany Greece Hungary +7

  • Study on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Rbl005.3
    • Rbl007.2
    • Rbl012.2
    Germany Poland Spain

  • Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ivonescimab
    • Carboplatin
    • Paclitaxel
    France Germany Greece Ireland Italy Poland +1

  • Study comparing XL092 plus nivolumab versus sunitinib for patients with advanced or metastatic non-clear cell kidney cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Nivolumab
    • Sunitinib
    Bulgaria Croatia Czechia Denmark Finland France +8

  • Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Fenebrutinib
    • Teriflunomide
    Austria Bulgaria Denmark France Greece Italy +1

  • Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Austria Czechia Germany Greece Hungary Latvia +3

  • Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cobolimab
    • Dostarlimab
    • Docetaxel
    Belgium Finland France Germany Greece Italy +5

  • Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

    Not recruiting

    3 1
    Investigated Drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6

  • Comparing bemnifosbuvir-ruzasvir and sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in adult patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ruzasvir
    • SOFOSBUVIR
    • VELPATASVIR
    France Germany Greece Poland Romania Spain
Previous Page
1 2 3 4 5 6 … 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!